The nonclinical Evaluation of the Potential for delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NONCLINICAL EVALUATION OF THE POTENTIAL FOR DELAYED VENTRICULAR REPOLARIZATION (QT INTERVAL PROLONGATION) BY HUMAN PHARMACEUTICALS (C
The nonclinical Evaluation of the Potential for delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NONCLINICAL EVALUATION OF THE POTENTIAL FOR DELAYED VENTRICULAR REPOLARIZATION (QT INTERVAL PROLONGATION) BY HUMAN PHARMACEUTICALS (C
复制标题
人类药物延迟心室复极(QT 间期延长)潜力的非临床评估步骤 5 人类药物延迟心室复极(QT 间期延长)潜力非临床评估指导说明(C)
DOI:
--
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
Jen Sheen (phase‐extraction)
中科院分区:
文献类型:
--
作者:
R. Kingston;Jen Sheen (phase‐extraction)
INTRODUCTION The assessment of the effects of pharmaceuticals on ventricular repolarization and proarrhythmic risk is the subject of active investigation. When additional data (non-clinical and clinical) are accumulated in the future, they will be evaluated and this guideline might be revised. 1.1 Objective of the Guideline This guideline describes a non-clinical testing strategy for assessing the potential of a test substance to delay ventricular repolarization. This guideline includes information concerning non-clinical assays and integrated risk assessments. 1.2 Background The QT interval (time from the beginning of the QRS complex to the end of the T wave) of the electrocardiogram (ECG) is a measure of the duration of ventricular depolarization and repolarization. QT interval prolongation can be congenital or acquired (e.g., pharmaceutical-induced). When ventricular repolarization is delayed and the QT interval is prolonged, there is an increased risk of ventricular tachyarrhythmia, including torsade de pointes, particularly when combined with other risk factors (e.g., hypokalemia, structural heart disease, bradycardia). Thus, much emphasis has been placed on the potential proarrhythmic effects of pharmaceuticals that are associated with QT interval prolongation. Ventricular repolarization, determined by the duration of the cardiac action potential, is a complex physiological process. It is the net result of the activities of many membrane ion channels and transporters. Under physiological conditions, the functions of these ion channels and transporters are highly interdependent. The activity of each ion channel or transporter is affected by multiple factors including, but not limited to, intracellular and extracellular ion concentrations, membrane potential, cell-to-cell electrical coupling, heart rate, and autonomic nervous system activity. The metabolic state (e.g., acid-base balance) and location and type of cardiac cell are also important. The human ventricular action potential consists of five sequential phases: • phase 0: The upstroke of the action potential is primarily a consequence of a rapid, transient influx of Na + (I Na) through Na + channels. • phase 1: The termination of the upstroke of the action potential and early repolarization phase result from the inactivation of Na + channels and the transient efflux of K + (I to) through K + channels. • phase 2: The plateau of the action potential is a reflection of a balance between the influx of Ca 2+ (I Ca) through L-type Ca 2+ channels and outward repolarizing K + currents. • phase 3: The sustained downward stroke of the action potential and the late repolarization phase result from the …